过敏性疾病和喘的经济影响-HEAD泛欧洲注册表
Ioana Agache1, Maria Torres2, Ibon Eguiluz-Gracia2
1Allergy & Clinical Immunology, Transylvania University, Brasov, Romania.
Allergy
|May 20, 2025
概括
过敏性疾病健康经济学 (HEAD) 注册表揭示了与过敏性鼻炎,喘,亚托皮炎和食物过敏相关的重大成本. 这些条件给医疗保健系统,社会和患者带来了巨大的经济负担,需要改进管理策略.
科学领域:
- 过敏和临床免疫学
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 过敏性疾病是一个重大的全球健康挑战,具有相当大的经济影响.
- 标准化管理和数据收集对于理解和解决过敏疾病的经济负担至关重要.
- 欧洲过敏和临床免疫学会开发了过敏疾病健康经济学 (HEAD) 注册表,以促进这一点.
研究的目的:
- 使用HEAD注册表来描述使用HEAD注册表来描述过敏疾病的护理模式.
- 量化过敏疾病对医疗保健系统,社会和患者的影响.
- 识别不同国家的成本驱动因素和管理方面的差异.
主要方法:
- 基于HEAD注册表的数据使用的基于注册表的观察性研究.
- 包括778名被诊断患有过敏性鼻炎,喘,亚托皮炎或食物过敏的成人和儿童.
- 数据来自四个欧洲国家:比利时,意大利,罗马尼亚和西班牙.
主要成果:
- 每名患者的平均年度总成本为1329.55.5欧元.
- 直接费用包括住院,急诊室,专家咨询,初级保健,心理学,诊断和治疗.
- 间接成本包括咨询,药物,运输,保险,避开和环境控制的自费费用,以及错过的工作/上学的时间.
结论:
- 过敏性疾病给个人,医疗保健系统和社会带来了巨大的经济负担.
- 各国在管理模式和成本方面观察到显著的异质性.
- 迫切需要改进管理策略,以减轻过敏疾病的经济影响.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
503
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
503
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-III: Symptoms and Complications
2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.7K
Asthma: Pathogenesis and Management
628
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
628
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


